Program
Download the abstract book: 4th IAAASS ABSTRACT-BOOK
| 2018.09.24 | ||||
| 5.00 pm | Registration | |||
| 6.00 pm | Remarks | |||
| EnzoTramontano | Organizing Committee Coordinator | |||
| Giorgio Palù | President of the European Society for Virology and of the Società Italiana di Virologia Italian Society for Virology – SIV-ISV | |||
| José Esté | President of the International Society for Antiviral Research | |||
| Inaugural Lecture | ||||
| José Esté | Host-pathogen interactions and antiviral drug potency | |||
| Fundaciò Irsicaixa (Spain) | ||||
| 2018.09.25 | ||||
| 9.00 am | Plenary lectures | |||
| Stephan Ludwig | Structural Targeting signal transduction pathways to fight the flu | |||
| University of Münster, Germany | ||||
| Stuart Le Grice | Small molecule targeting of viral RNA regulatory elements | |||
| National Cancer Institute (USA) | ||||
| 11.00-11.15 am | Coffee Break | |||
| 11.15 am | Plenary lectures | |||
| Andrea Brancale | Computer-aided design of novel antivirals | |||
| Cardiff University (UK) | ||||
| Giorgio Palù | Functionality and druggability of the E6 oncoprotein of HPV | |||
| University of Padova | ||||
| 1.00-2.00 pm | Lunch | |||
| 2.00-3.30 pm | Poster session 1 | |||
| 3.30-5.00 pm | Selected oral communications | |||
| 6.00 pm | Coffee break | |||
| 6.30-7.30 pm | Discussion groups | |||
| 2018.09.26 | ||||
| 9.00 am | Plenary lectures | |||
| Raffaele De Francesco | From the elucidation of HCV life-cycle to the development of highly effective antivirals | |||
|
INGM, Italy |
||||
| Vincenzo Summa | Discovery of Grazoprevir an HCV pangenotype protease inhibitor approved for interferon free therapy to cure the HCV infected patients | |||
| IRBM (Italy) | ||||
| 11.00-11.15 am | Coffee Break | |||
| 11.15 am | Round table: Working in a company after the PhD
Timothy Tellinghuisen (Hoffmann-La Roche) Vincenzo Summa (IRBM) Stuart Le Grice (NCI) Franco Lori (Virostatics) |
|||
| 1.00-2.00 pm | Lunch | |||
| 2.00-3.30 pm | Poster session and Bio-tech companies presentation desk | |||
| 3.30-5.00 pm | Selected oral communications | |||
| 6.00 pm | Coffee break | |||
| 6.30-7.30 pm | Discussion groups | |||
| 2018.09.27 | ||||
| 9.00 am | Plenary lectures | |||
| Zlatko Janeba | The progress in development of inhibitors of viral reverse transcriptase | |||
| University of Prague, Czech Republic | ||||
| Michelle Hastings | Therapeutic Targeting of Gene Expression with Antisense | |||
| Rosalind Franklin University, USA | ||||
| 11.00-11.15 am | Coffee Break | |||
| 11.15 am | Plenary lectures | |||
| Reuben Harris | Targeting Evolvability | |||
| University of Minnesota (USA) | ||||
| Maurizio Botta | Antiviral compounds with broad spectrum activity on enveloped viruses | |||
| University of Siena (Italy) | ||||
| 1.00 pm | Lunch | |||
| Free afternoon | ||||
| 2018.09.28 | ||||
| 9.00 am | Plenary lectures | |||
| Thomas Mertens | Re-emergence of antibodies in antiviral therapy | |||
| University of Ulm (Germany) | ||||
| Daniel Appella | Disrupting HIV Nucleocapsid Protein with Mercaptobenzamides | |||
| NIH (USA) | ||||
| 11.00-11.15 am | Coffee Break | |||
| 11.15 am | Plenary lectures | |||
| Graciela Andrei | Viral DNA polymerases: effects of amino acid substitutions on viral adaptation and evolution | |||
| KU Leuven (Belgium) | ||||
| Simona Distinto | In silico virtual screening approaches for antiviral drug discovery | |||
| University of Cagliari (Italy) | ||||
| 1.00-2.00 pm | Lunch | |||
| 2.00-3.00 pm | Poster session | |||
| 3.00-5.00 pm | Selected oral communications | |||
| 6.00 pm | Coffee break | |||
| 6.30-7.30 pm | Discussion groups | |||
| 2018.09.29 | ||||
| Breakfast and leaving | ||||